{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:52:51Z","timestamp":1790301171682,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Nano-biofarmac\u00eautica (INCT-NanoBiofar)","award":["CBB-APQ-00819-12"],"award-info":[{"award-number":["CBB-APQ-00819-12"]}]},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Nano-biofarmac\u00eautica (INCT-NanoBiofar)","award":["CBB-APQ-01778-2014"],"award-info":[{"award-number":["CBB-APQ-01778-2014"]}]},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Nano-biofarmac\u00eautica (INCT-NanoBiofar)","award":["APQ-482976\/2012-8"],"award-info":[{"award-number":["APQ-482976\/2012-8"]}]},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Nano-biofarmac\u00eautica (INCT-NanoBiofar)","award":["APQ-488237\/2013-0"],"award-info":[{"award-number":["APQ-488237\/2013-0"]}]},{"name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Nano-biofarmac\u00eautica (INCT-NanoBiofar)","award":["APQ-467640\/2014-9"],"award-info":[{"award-number":["APQ-467640\/2014-9"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parasitology International"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.parint.2016.07.005","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T22:17:38Z","timestamp":1468707458000},"page":"728-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"PA","title":["Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system"],"prefix":"10.1016","volume":"65","author":[{"given":"Mariana Costa","family":"Duarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Let\u00edcia Martins dos Reis","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Pagliara","family":"Lage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edvian Tamietti","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Maria Ravena Severino","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Mendes","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Menezes-Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Alberto Pereira","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo Jos\u00e9","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M\u00e1rio","family":"Barichello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Antonio Ferraz","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.parint.2016.07.005_bb0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","article-title":"Personal view visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda personal view","volume":"2","author":"Guerin","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.parint.2016.07.005_bb0010","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"Chappuis","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.parint.2016.07.005_bb0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003527","article-title":"Health economic evaluations of visceral leishmaniasis treatments: a systematic review","volume":"9","author":"Marinho","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parint.2016.07.005_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2016.07.005_bb0025","series-title":"Topley & Wilson's Microbiology and Microbial Infections: Parasitology","first-page":"313","article-title":"New world leishmaniasis","author":"Lainson","year":"2005"},{"key":"10.1016\/j.parint.2016.07.005_bb0030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ijpara.2005.07.001","article-title":"The current status of zoonotic leishmaniases and approaches to disease control","volume":"35","author":"Gramiccia","year":"2005","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.parint.2016.07.005_bb0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actatropica.2011.05.012","article-title":"Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human","volume":"119","author":"Michel","year":"2011","journal-title":"Acta Trop."},{"key":"10.1016\/j.parint.2016.07.005_bb0040","first-page":"378","article-title":"Liposomal amphotericin B versus pentavalent antimony salts for visceral Leishmania in children","volume":"55","author":"Apa","year":"2013","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.parint.2016.07.005_bb0045","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.3390\/ijerph7124267","article-title":"Antimony toxicity","volume":"7","author":"Sundar","year":"2010","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.parint.2016.07.005_bb0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1086\/341406","article-title":"A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel","volume":"35","author":"Wortmann","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parint.2016.07.005_bb0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4269\/ajtmh.2001.65.456","article-title":"Comparison of cutaneous leishmaniasis due to Leishmania (Viannia) braziliensis and L. (V.) guyanensis in Brazil: therapeutic response to meglumine antimoniate","volume":"65","author":"Romero","year":"2001","journal-title":"Am.J.Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2016.07.005_bb0060","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-3156.2001.00778.x","article-title":"Drug resistance in Indian visceral leishmaniasis","volume":"6","author":"Sundar","year":"2001","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.parint.2016.07.005_bb0065","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis: current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.parint.2016.07.005_bb0070","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1590\/S0037-86821985000300011","article-title":"Pentavalent antimonials: old drugs for new diseases","volume":"18","author":"Marsden","year":"1985","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.parint.2016.07.005_bb0075","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1365-3024.1995.tb00962.x","article-title":"Cytotoxicity in human mucosal and cutaneous leishmaniasis","volume":"17","author":"Barral-Netto","year":"1995","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.parint.2016.07.005_bb0080","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/380638","article-title":"Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India","volume":"38","author":"Bhattacharya","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.parint.2016.07.005_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1039\/b402985m","article-title":"Natural products to drugs: natural product derived compounds in clinical trials","volume":"22","author":"Butler","year":"2005","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.parint.2016.07.005_bb0090","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd1086","article-title":"Hit and lead generation: beyond high-throughput screening","volume":"2","author":"Bleicher","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.parint.2016.07.005_bb0095","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.parint.2016.07.005_bb0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1590\/0037-8682-0138-2015","article-title":"New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment","volume":"48","author":"Ch\u00e1vez-Fumagalli","year":"2015","journal-title":"Rev. Soc. Bras. Med. Trop."},{"issue":"36","key":"10.1016\/j.parint.2016.07.005_bb0105","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.2174\/138161206779026245","article-title":"Polymeric micelle for drug delivery","volume":"12","author":"Croy","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.parint.2016.07.005_bb0110","first-page":"955","article-title":"Inhibitory effects of gallium chloride and tris(8-quinolinolato) gallium III on A549 human malignant cell line","volume":"20","author":"Collery","year":"2000","journal-title":"Anticancer Res."},{"key":"10.1016\/j.parint.2016.07.005_bb0115","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1023\/A:1007534416561","article-title":"Synthesis and cytotoxic evaluation of a series of gamma-substituted gamma-aryloxymethyl-alpha-methylene-gamma-butyrolactones against cancer cells","volume":"17","author":"Tzeng","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.parint.2016.07.005_bb0120","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/A:1007120913871","article-title":"New antifungal agents that inhibit the growth of Candida species: dichlorinated 8-quinolinols","volume":"147","author":"Lentz","year":"1999","journal-title":"Mycopathologia"},{"key":"10.1016\/j.parint.2016.07.005_bb0125","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0024-3205(98)00623-7","article-title":"A chelating agent possessing cytotoxicity and antimicrobial activity: 7-morpholinomethyl-8-hydroxyquinoline","volume":"64","author":"Shen","year":"1999","journal-title":"Life Sci."},{"key":"10.1016\/j.parint.2016.07.005_bb0130","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2147\/DDDT.S49763","article-title":"8-hydroxyquinolines: a review of their metal chelating properties and medicinal applications","volume":"7","author":"Prachayasittikul","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.parint.2016.07.005_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejmech.2012.04.029","article-title":"Discovery of a new antileishmanial hit in 8-nitroquinoline series","volume":"54","author":"Paloque","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.parint.2016.07.005_bb0140","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ejmech.2015.07.018","article-title":"Synthesis, leishmanicidal, trypanocidal and cytotoxic activity of quinoline-hydrazone hybrids","volume":"101","author":"Coa","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.parint.2016.07.005_bb0145","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.vetpar.2016.01.002","article-title":"An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis","volume":"217","author":"Duarte","year":"2016","journal-title":"Vet. Parasitol."},{"key":"10.1016\/j.parint.2016.07.005_bb0150","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0378-5173(99)00119-2","article-title":"Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats","volume":"184","author":"Barichello","year":"1999","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.parint.2016.07.005_bb0155","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.parint.2016.07.005_bb0160","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/0014-4894(91)90104-5","article-title":"Leishmania donovani: long-term culture of axenic amastigotes at 37\u00b0C","volume":"73","author":"Doyle","year":"1991","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.parint.2016.07.005_bb0165","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1007\/s00436-015-4708-4","article-title":"Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum","volume":"114","author":"Lage","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.parint.2016.07.005_bb0170","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.parint.2011.06.001","article-title":"Leishmanicidal activity of the Agaricus blazei Murill in different Leishmania species","volume":"60","author":"Valadares","year":"2011","journal-title":"Parasitol. Int."},{"key":"10.1016\/j.parint.2016.07.005_bb0175","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","article-title":"A limiting dilution assay for quantifying Leishmania major in tissues of infected mice","volume":"7","author":"Titus","year":"1985","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.parint.2016.07.005_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/427655ac-c278-41f5-95ca-6279c562752f","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"Martins","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parint.2016.07.005_bb0185","article-title":"Canine skin and conjunctival swab samples for the detection and quantification of Leishmania infantum DNA in an endemic urban area in Brazil","volume":"6","author":"Ferreira","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.parint.2016.07.005_bb0190","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/pim.12287","article-title":"Prophylactic properties of a Leishmania-specific hypothetical protein in a murine model of visceral leishmaniasis","volume":"37","author":"Lage","year":"2015","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.parint.2016.07.005_bb0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049780","article-title":"Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation","volume":"7","author":"Roatt","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.parint.2016.07.005_bb0200","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","article-title":"Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids","volume":"126","author":"Green","year":"1982","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.parint.2016.07.005_bb0205","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s13071-015-0964-5","article-title":"A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis","volume":"8","author":"Martins","year":"2015","journal-title":"Parasitol. Vectors"},{"key":"10.1016\/j.parint.2016.07.005_bb0210","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/s00436-011-2628-5","article-title":"Evaluation of parasitological and immunological parameters of Leishmania chagasi infection in BALB\/c mice using different doses and routes of inoculation of parasites","volume":"110","author":"Oliveira","year":"2012","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.parint.2016.07.005_bb0215","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am.J.Trop. Med. Hyg."},{"key":"10.1016\/j.parint.2016.07.005_bb0220","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1128\/AAC.35.6.1208","article-title":"Comparative pharmacokinetics of amphotericin B after administration of a novel colloidal delivery system, ABCD, and a conventional formulation to rats","volume":"35","author":"Fielding","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2016.07.005_bb0225","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jac\/dkp140","article-title":"Pharmacokinetics and biodistribution of amphotericin B in rats following oral administration in a novel lipid-based formulation","volume":"64","author":"Gershkovich","year":"2009","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.parint.2016.07.005_bb0230","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/10611860290007513","article-title":"Superior chemotherapeutic efficacy of amphotericin B in tuftsin-bearing liposomes against Leishmania donovani infection in hamsters","volume":"10","author":"Agrawal","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.parint.2016.07.005_bb0235","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2147\/nano.2006.1.4.417","article-title":"Optimizing efficacy of amphotericin B through nanomodification","volume":"1","author":"Vyas","year":"2006","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.parint.2016.07.005_bb0240","first-page":"877","article-title":"Novel targeting using nanoparticles: an approach to the development of an effective anti-leishmanial drug delivery system","volume":"14","author":"Ribeiro","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.parint.2016.07.005_bb0245","first-page":"5341","article-title":"An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis","volume":"9","author":"Ribeiro","year":"2014","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.parint.2016.07.005_bb0250","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2217\/17435889.3.3.367","article-title":"Micro\/nanostructured polymeric systems for biomedical and pharmaceutical applications","volume":"3","author":"Chiellini","year":"2008","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.parint.2016.07.005_bb0255","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jconrel.2015.04.032","article-title":"Recent progress in biomedical applications of Pluronic (PF127): pharmaceutical perspectives","volume":"209","author":"Akash","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.parint.2016.07.005_bb0260","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.addr.2011.08.003","article-title":"Protein stabilization by cyclodextrins in the liquid and dried state","volume":"63","author":"Serno","year":"2011","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.parint.2016.07.005_bb0265","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/S0142-9612(01)00050-3","article-title":"Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification","volume":"22","author":"Torchilin","year":"2001","journal-title":"Biomaterials"},{"key":"10.1016\/j.parint.2016.07.005_bb0270","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/713840400","article-title":"Development and characterization of transdermal drug delivery systems for diltiazem hydrochloride","volume":"10","author":"Jain","year":"2003","journal-title":"Drug Deliv."},{"key":"10.1016\/j.parint.2016.07.005_bb0275","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpharm.2006.12.033","article-title":"Difunctional Pluronic copolymer micelle for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines","volume":"337","author":"Wang","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.parint.2016.07.005_bb0280","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.biomaterials.2010.12.039","article-title":"Multifunctional Pluronic P123\/F127 mixed polymeric micelle loaded with paclitaxel for the treatment of multidrug resistant tumors","volume":"32","author":"Zhang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.parint.2016.07.005_bb0285","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pdpdt.2014.10.005","article-title":"Polymeric micelle for enhanced Photofrin II\u00ae delivery, cytotoxicity and pro-apoptotic activity in human breast and ovarian cancer cells","volume":"11","author":"Lamch","year":"2014","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"10.1016\/j.parint.2016.07.005_bb0290","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis","volume":"123","author":"Garg","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.parint.2016.07.005_bb0295","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2217\/nnm.14.102","article-title":"Developing cutaneous applications of pamamomycin entrapped in stimuli-sensitive block copolymer nanogeldispersions","volume":"10","author":"Brugu\u00e9s","year":"2015","journal-title":"Nanomedicine (London)"},{"key":"10.1016\/j.parint.2016.07.005_bb0300","first-page":"9","article-title":"Strychnos pseudoquina and its purified compounds present an effective in vitro antileishmanial activity","volume":"1","author":"Lage","year":"2013","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.parint.2016.07.005_bb0305","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jep.2015.02.047","article-title":"Antileishmanial activity of standardized fractions of Stryphnodendron obovatum (Barbatim\u00e3o) extract and constituent compounds","volume":"165","author":"Ribeiro","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.parint.2016.07.005_bb0310","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.exppara.2012.07.005","article-title":"Prophylactic or therapeutic administration of Agaricus blazei Murill is effective in treatment of murine visceral leishmaniasis","volume":"132","author":"Valadares","year":"2012","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.parint.2016.07.005_bb0315","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-3024.2006.00817.x","article-title":"Immunohistological features of visceral leishmaniasis in BALB\/c mice","volume":"28","author":"Carri\u00f3n","year":"2006","journal-title":"Parasite Immunol."},{"key":"10.1016\/j.parint.2016.07.005_bb0320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/IAI.66.1.18-27.1998","article-title":"Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani","volume":"66","author":"Melby","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.parint.2016.07.005_bb0325","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0167-5699(99)01549-2","article-title":"Organ-specific immune responses associated with infectious disease","volume":"21","author":"Engwerda","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.parint.2016.07.005_bb0330","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1128\/IAI.71.1.401-410.2003","article-title":"Intradermal infection model for pathogenesis and vaccine studies of murine visceral leishmaniasis","volume":"71","author":"Ahmed","year":"2003","journal-title":"Infect. Immunol."},{"key":"10.1016\/j.parint.2016.07.005_bb0335","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1006\/bbrc.2000.4175","article-title":"Bothrops moojeni venom kills Leishmania spp. with hydrogen peroxide generated by its l-amino acid oxidase","volume":"280","author":"Tempone","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.parint.2016.07.005_bb0340","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1007\/s00436-015-4708-4","article-title":"Antileishmanial activity and evaluation of the mechanism of action of strychnobiflavone flavonoid isolated from Strychnos pseudoquina against Leishmania infantum","volume":"114","author":"Lage","year":"2015","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.parint.2016.07.005_bb0345","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/AAC.38.2.363","article-title":"Physicochemical cell damage in relation to lethal amphotericin B action","volume":"38","author":"Beggs","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.parint.2016.07.005_bb0350","series-title":"Drug Transport in Antimicrobial and Anticancer Chemotherapy","first-page":"307","article-title":"Internalisation of amphotericin B and other polyene antifungals in mammalian cells: a possible origin of their toxicity","author":"Bolard","year":"1995"},{"key":"10.1016\/j.parint.2016.07.005_bb0355","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2016.05.007","article-title":"8-Hydroxyquinolines in medicinal chemistry: a structural perspective","volume":"120","author":"Oliveri","year":"2016","journal-title":"Eur. J. Med. Chem."}],"container-title":["Parasitology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576916302240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383576916302240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T02:08:53Z","timestamp":1600913333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383576916302240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":71,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1383576916302240"],"URL":"https:\/\/doi.org\/10.1016\/j.parint.2016.07.005","relation":{},"ISSN":["1383-5769"],"issn-type":[{"value":"1383-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of murine visceral leishmaniasis using an 8-hydroxyquinoline-containing polymeric micelle system","name":"articletitle","label":"Article Title"},{"value":"Parasitology International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parint.2016.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}